Efficacy of Dalbavancin in Osteoarticular Infections Associated With Hip and Knee Replacements

NARecruitingINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

March 7, 2022

Primary Completion Date

September 30, 2024

Study Completion Date

September 30, 2024

Conditions
Osteoarticular Infection
Interventions
DRUG

Dalbavancin

"The unit dose of dalbavancin administered via the peripheral venous route will be 1500 mg at each injection with a first injection at Day1, a second injection at Day15 and a third at Day36, which corresponds to 61 days of treatment with dalbavancin.~In case of residual dalbavancin dosage at Day15 lower than 15 mg/L (rare situation) and a minimal inhibitory concentration for dalbavancin of 0.125mg/L (less than 5% of the strains), an injection every 14 days will be necessary, i.e. Day1, Day15, Day29, Day43 and Day57, which corresponds to 71 days of dalbavancin treatment.~Rifampicin should be given orally at a dose of 600 mg on an empty stomach in the morning for patients weighing less than 70 kg and 900 mg on an empty stomach in the morning for patients weighing more than 70 kg."

Trial Locations (4)

37000

RECRUITING

CHRU de TOURS, Tours

59208

RECRUITING

Centre Hospitalier de Tourcoing, Tourcoing

92100

RECRUITING

AP-HP - Hôpital Ambroise-Paré, Boulogne-Billancourt

Unknown

RECRUITING

CHU de Nice, Nice

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Nice

OTHER